Tafamidis treats transthyretin amyloid cardiomyopathy

(HealthDay)β€”In patients with transthyretin amyloid cardiomyopathy, treatment with tafamidis reduces all-cause mortality and cardiovascular-related hospitalizations versus placebo, according to a study published in the Sept. ...

Alzheimer's disease & dementia

Researchers identify new potential biotherapy for Alzheimer's disease

Researchers at the University of Florida have discovered that a modified version of an important immune cell protein could be used to treat Alzheimer's disease. The study, which will be published August 29 in the Journal ...

page 9 from 23